Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque.
Stone GW, Maehara A, Ali ZA, Held C, Matsumura M, Kjøller-Hansen L, Bøtker HE, Maeng M, Engstrøm T, Wiseth R, Persson J, Trovik T, Jensen U, James SK, Mintz GS, Dressler O, Crowley A, Ben-Yehuda O, Erlinge D; PROSPECT ABSORB Investigators. Stone GW, et al. J Am Coll Cardiol. 2020 Nov 17;76(20):2289-2301. doi: 10.1016/j.jacc.2020.09.547. Epub 2020 Oct 15. J Am Coll Cardiol. 2020. PMID: 33069847 Free article. Clinical Trial.
Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein.
Penny WF, Ben-Yehuda O, Kuroe K, Long J, Bond A, Bhargava V, Peterson JF, McDaniel M, Juliano J, Witztum JL, Ross J Jr, Peterson KL. Penny WF, et al. J Am Coll Cardiol. 2001 Mar 1;37(3):766-74. doi: 10.1016/s0735-1097(00)01180-3. J Am Coll Cardiol. 2001. PMID: 11693750 Free article.
Severe ostial saphenous vein graft disease leading to acute coronary syndromes following proximal aorto-saphenous anastomoses with the symmetry bypass connector device: is it a suture device or a "stent"?
Cavendish JJ, Penny WF, Madani MM, Keramati S, Ben-Yehuda O, Blanchard DG, Mahmud E, Perricone A, Tsimikas S. Cavendish JJ, et al. J Am Coll Cardiol. 2004 Jan 7;43(1):133-9. doi: 10.1016/j.jacc.2003.09.028. J Am Coll Cardiol. 2004. PMID: 14715195 Free article.
Highlights of the Year in JACC 2006.
DeMaria AN, Ben-Yehuda O, Feld GK, Ginsburg GS, Greenberg BH, Lew WY, Lima JA, Maisel AS, Narula J, Sahn DJ, Tsimikas S. DeMaria AN, et al. J Am Coll Cardiol. 2007 Jan 30;49(4):509-27. doi: 10.1016/j.jacc.2006.12.008. Epub 2007 Jan 16. J Am Coll Cardiol. 2007. PMID: 17258099 Free article. Review. No abstract available.
Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial.
Weisz G, Farzaneh-Far R, Ben-Yehuda O, Debruyne B, Montalescot G, Lerman A, Mahmud E, Alexander KP, Ohman EM, White HD, Olmsted A, Walker GA, Stone GW. Weisz G, et al. Am Heart J. 2013 Dec;166(6):953-959.e3. doi: 10.1016/j.ahj.2013.08.004. Epub 2013 Oct 16. Am Heart J. 2013. PMID: 24268208 Clinical Trial.
Clinical profile and impact of family history of premature coronary artery disease on clinical outcomes of patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial.
Ertelt K, Généreux P, Mintz GS, Brener SJ, Kirtane AJ, McAndrew TC, Francese DP, Ben-Yehuda O, Mehran R, Stone GW. Ertelt K, et al. Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):375-80. doi: 10.1016/j.carrev.2014.09.002. Epub 2014 Sep 16. Cardiovasc Revasc Med. 2014. PMID: 25288517
243 results